Currently, there are 100.17M common shares owned by the public and among those 98.00M shares have been available to trade.
The company’s stock has a 5-day price change of 2.22% and 2.94% over the past three months. AMP shares are trading 18.33% year to date (YTD), with the 12-month market performance up to 32.13% higher. It has a 12-month low price of $306.63 and touched a high of $449.94 over the same period. AMP has an average intraday trading volume of 482.95K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 6.81%, 5.18%, and 10.22% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Ameriprise Financial Inc (NYSE: AMP) shares accounts for 87.19% of the company’s 100.17M shares outstanding.
It has a market capitalization of $44.13B and a beta (3y monthly) value of 1.35. The stock’s trailing 12-month PE ratio is 15.40, while the earnings-per-share (ttm) stands at $29.19. The company has a PEG of 0.87 and the debt-to-equity ratio at 1.20. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.37% over the week and 1.72% over the month.
Earnings per share for the fiscal year are expected to increase by 17.63%, and 9.68% over the next financial year. EPS should grow at an annualized rate of 17.60% over the next five years, compared to 10.79% over the past 5-year period.
Evercore ISI coverage for the Ameriprise Financial Inc (AMP) stock in a research note released on January 04, 2024 offered a In-line rating with a price target of $400. Goldman was of a view on January 03, 2024 that the stock is Buy, while Morgan Stanley gave the stock Equal-Weight rating on December 22, 2023, issuing a price target of $365- $383. Keefe Bruyette on their part issued Mkt Perform rating on December 19, 2022.
